Joe Hsueh
Fondateur chez Act Genomics Co. Ltd.
Profil
Joe Hsueh is the founder of Act Genomics Co. Ltd.
He is currently working as the President of AnBogen Therapeutics, Inc. and as the Vice President-Corporate Operations at TaiGen Biotechnology Co., Ltd.
Mr. Hsueh has a Master's in Business Administration from Fairleigh Dickinson University and an undergraduate degree from Soochow University.
Postes actifs de Joe Hsueh
| Sociétés | Poste | Début |
|---|---|---|
TaiGen Biotechnology Co., Ltd.
 TaiGen Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology TaiGen Biotechnology Co., Ltd. is a research-based and product-driven pharmaceutical company engaging in the development of therapeutics for infectious diseases, cancer, and diabetes-related complications. Its activities include drug discovery, development, global regulatory, and commercialization in China. The company was founded by Ming-Chu Hsu in 2001 and is headquartered in Taipei, Taiwan. | Directeur des opérations | 02/10/2012 |
Act Genomics Co. Ltd.
 Act Genomics Co. Ltd. Hospital/Nursing ManagementHealth Services ACT Genomics Co. Ltd. develops cancer molecular information and therapeutic solutions. It specializes in oncology, cancer genomics, and bioinformatics. The company was founded by Shu Jen Chen and Hua Chien Chen in 2014 and is headquartered in Taipei, Taiwan. | Fondateur | - |
AnBogen Therapeutics, Inc.
 AnBogen Therapeutics, Inc. BiotechnologyHealth Technology AnBogen Therapeutics, Inc. is a clinical-stage biotech company based in Taiwan. AnBogen Therapeutics is dedicated to designing and developing precision oncology therapies to improve the lives of patients. The Taiwanese company aims to bridge the gap between research and clinical development and create breakthrough science that meaningfully changes the lives of patients. AnBogen Therapeutics' collective experience in medicinal chemistry, cancer biology, drug discovery, and clinical development enables the development of a differentiated pipeline in the field of precision oncology. AnBogen Therapeutics, Inc. was founded by a group of scientists from the National Health Research Institute. The company was founded by Tsu-An Hsu, who has been the CEO since incorporation. | President | - |
Formation de Joe Hsueh
| Fairleigh Dickinson University | Masters Business Admin |
| Soochow University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
TaiGen Biotechnology Co., Ltd.
TaiGen Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology TaiGen Biotechnology Co., Ltd. is a research-based and product-driven pharmaceutical company engaging in the development of therapeutics for infectious diseases, cancer, and diabetes-related complications. Its activities include drug discovery, development, global regulatory, and commercialization in China. The company was founded by Ming-Chu Hsu in 2001 and is headquartered in Taipei, Taiwan. | Health Technology |
Act Genomics Co. Ltd.
Act Genomics Co. Ltd. Hospital/Nursing ManagementHealth Services ACT Genomics Co. Ltd. develops cancer molecular information and therapeutic solutions. It specializes in oncology, cancer genomics, and bioinformatics. The company was founded by Shu Jen Chen and Hua Chien Chen in 2014 and is headquartered in Taipei, Taiwan. | Health Services |
AnBogen Therapeutics, Inc.
AnBogen Therapeutics, Inc. BiotechnologyHealth Technology AnBogen Therapeutics, Inc. is a clinical-stage biotech company based in Taiwan. AnBogen Therapeutics is dedicated to designing and developing precision oncology therapies to improve the lives of patients. The Taiwanese company aims to bridge the gap between research and clinical development and create breakthrough science that meaningfully changes the lives of patients. AnBogen Therapeutics' collective experience in medicinal chemistry, cancer biology, drug discovery, and clinical development enables the development of a differentiated pipeline in the field of precision oncology. AnBogen Therapeutics, Inc. was founded by a group of scientists from the National Health Research Institute. The company was founded by Tsu-An Hsu, who has been the CEO since incorporation. | Health Technology |
